Co-Diagnostics to Hold Press Conference
Media, analysts and investors are welcome to attend in person or via live webcast, Sept. 16 at 10:30 a.m. ET SALT LAKE CITY, Sept. 15, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.